KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Edwards Lifesciences (EW) Non-Current Assets (2016 - 2025)

Edwards Lifesciences (EW) has 17 years of Non-Current Assets data on record, last reported at $7.0 billion in Q4 2025.

  • For Q4 2025, Non-Current Assets rose 2.78% year-over-year to $7.0 billion; the TTM value through Dec 2025 reached $27.6 billion, up 14.2%, while the annual FY2025 figure was $7.0 billion, 2.78% up from the prior year.
  • Non-Current Assets reached $7.0 billion in Q4 2025 per EW's latest filing, up from $6.9 billion in the prior quarter.
  • Across five years, Non-Current Assets topped out at $7.0 billion in Q4 2025 and bottomed at $4.1 billion in Q1 2021.
  • Average Non-Current Assets over 5 years is $5.6 billion, with a median of $5.3 billion recorded in 2023.
  • Peak YoY movement for Non-Current Assets: rose 28.36% in 2021, then dropped 2.35% in 2022.
  • A 5-year view of Non-Current Assets shows it stood at $5.3 billion in 2021, then decreased by 2.35% to $5.2 billion in 2022, then increased by 2.52% to $5.3 billion in 2023, then increased by 27.07% to $6.8 billion in 2024, then rose by 2.78% to $7.0 billion in 2025.
  • Per Business Quant database, its latest 3 readings for Non-Current Assets were $7.0 billion in Q4 2025, $6.9 billion in Q3 2025, and $6.9 billion in Q2 2025.